Literature DB >> 25973730

H-Chain Ferritin: A Natural Nuclei Targeting and Bioactive Delivery Nanovector.

Lianbing Zhang1, Le Li1, Alessandra Di Penta2,3, Unai Carmona1, Fan Yang1, Regina Schöps4, Matthias Brandsch5, José L Zugaza2,6,7, Mato Knez1,7.   

Abstract

Keywords:  drug delivery; heavy-chain ferritin; nuclei translocation; organotypic culture; subcellular targeting

Mesh：

Substances：

Year:  2015        PMID： 25973730     DOI： 10.1002/adhm.201500226

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN： 2192-2640            Impact factor:   9.933


× No keyword cloud information.
  12 in total

Review 1.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

Review 2.  Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting.

Authors:  Makan Khoshnejad; Hamideh Parhiz; Vladimir V Shuvaev; Ivan J Dmochowski; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2018-03-06       Impact factor: 9.776

3.  Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System.

Authors:  Zuzana Skubalova; Simona Rex; Martina Sukupova; Martin Zahalka; Petr Skladal; Jan Pribyl; Hana Michalkova; Akila Weerasekera; Vojtech Adam; Zbynek Heger
Journal:  Int J Nanomedicine       Date:  2021-01-06

4.  Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.

Authors:  Verena Damiani; Elisabetta Falvo; Giulio Fracasso; Luca Federici; Martina Pitea; Vincenzo De Laurenzi; Gianluca Sala; Pierpaolo Ceci
Journal:  Int J Mol Sci       Date:  2017-07-18       Impact factor: 5.923

5.  Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.

Authors:  Serena Mazzucchelli; Michela Bellini; Luisa Fiandra; Marta Truffi; Maria A Rizzuto; Luca Sorrentino; Erika Longhi; Manuela Nebuloni; Davide Prosperi; Fabio Corsi
Journal:  Oncotarget       Date:  2017-01-31

6.  H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer.

Authors:  S Mazzucchelli; M Truffi; F Baccarini; M Beretta; L Sorrentino; M Bellini; M A Rizzuto; R Ottria; A Ravelli; P Ciuffreda; D Prosperi; F Corsi
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

7.  In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy.

Authors:  Kelong Fan; Juqun Xi; Lei Fan; Peixia Wang; Chunhua Zhu; Yan Tang; Xiangdong Xu; Minmin Liang; Bing Jiang; Xiyun Yan; Lizeng Gao
Journal:  Nat Commun       Date:  2018-04-12       Impact factor: 14.919

8.  Cryo-EM structure of the human ferritin-transferrin receptor 1 complex.

Authors:  Linda Celeste Montemiglio; Claudia Testi; Pierpaolo Ceci; Elisabetta Falvo; Martina Pitea; Carmelinda Savino; Alessandro Arcovito; Giovanna Peruzzi; Paola Baiocco; Filippo Mancia; Alberto Boffi; Amédée des Georges; Beatrice Vallone
Journal:  Nat Commun       Date:  2019-03-08       Impact factor: 14.919

9.  Tumor Accumulation and Off-Target Biodistribution of an Indocyanine-Green Fluorescent Nanotracer: An Ex Vivo Study on an Orthotopic Murine Model of Breast Cancer.

Authors:  Marta Sevieri; Leopoldo Sitia; Arianna Bonizzi; Marta Truffi; Serena Mazzucchelli; Fabio Corsi
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

Review 10.  An Up-to-Date Review of Natural Nanoparticles for Cancer Management.

Authors:  Daniel Ion; Adelina-Gabriela Niculescu; Dan Nicolae Păduraru; Octavian Andronic; Florentina Mușat; Alexandru Mihai Grumezescu; Alexandra Bolocan
Journal:  Pharmaceutics       Date:  2021-12-22       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.